No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 64
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Prevention
Participants needed
66 (estimated)
Sponsor
University of Colorado, Denver · Other
Who this trial is looking for
This trial is looking for people who are at risk of developing type 2 diabetes to see how breaking up sitting time with brief physical activity can help improve blood sugar levels. Participants will be asked to follow specific activity routines and wear a fitness tracker.
Are You a Good Fit for This Trial?
Must be takingMetformin
You may be able to join if
I am between 18 and 64 years old.
I have a BMI between 18.5 and 40.
I have been diagnosed with pre-diabetes.
I do not do more than 150 minutes of moderate to vigorous activity each week.
I sit for more than 6 hours a day.
I take Metformin to prevent diabetes.
I agree to follow a controlled diet for 3 days before visits.
I am willing to wear a Fitbit activity monitor.
You may not be able to join if
I am pregnant, breastfeeding, or post-menopause.
I have a history of serious medical conditions or substance abuse.
I have a history of cardiovascular disease or uncontrolled hypertension.
I test positive for HIV or hepatitis B or C.
I have donated over 400 mL of blood in the last 3 months.
I smoke or have smoked in the last 3 months.
I have abnormal blood tests that are concerning.
I work night shifts during the study.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Newly released guidelines recommend increased physical activity (PA) and reduced sedentary behaviors (SB) to improve glycemia and prevent the onset and progression of type 2 diabetes (T2D). Typically, 30-60 min bouts of PA are advocated per day. Although this approach increases PA, it does not decrease the length of the sedentary periods through the day. This is important because recent epidemiolo…
Newly released guidelines recommend increased physical activity (PA) and reduced sedentary behaviors (SB) to improve glycemia and prevent the onset and progression of type 2 diabetes (T2D). Typically, 30-60 min bouts of PA are advocated per day. Although this approach increases PA, it does not decrease the length of the sedentary periods through the day. This is important because recent epidemiological data suggest that frequently interrupting sedentary time improves glucose control even in people who achieve the recommended levels of PA. Preliminary experimental data suggest that breaking up prolonged sedentary time by performing multiple short bouts (5 min) of PA throughout the day, may improve glycemia more than performing a single continuous bout of PA, and thereby potentially be a novel strategy to prevent T2D. The improvement in glycemia was observed even when the total amount of PA and total energy expenditure were matched, suggesting that how and when PA is performed over the day may matter more than how much PA is done. However, important gaps in knowledge remain including: (1) whether similar benefits on glucose control would be observed in adults with prediabetes, a clinically relevant population that is at high risk of developing T2D; (2) whether these effects are sustained or diluted over time, and (3) what are the mechanistic underpinnings. To address these gaps, the investigators propose to measure the acute and chronic effects of PA breaks on glucose control and the underlying mechanisms in individuals at risk of developing T2D. Sedentary men and women with prediabetes (n=66, 50% F) will be randomized to either an intervention designed to interrupt SB with 5-min bouts of brisk walking performed hourly for 9 hours/day, 5 days/week (BREAK) or a control condition consisting of 45-min of brisk walking performed as a single daily continuous bout, 5 days/week (ONE). The two 3-months interventions will be matched for total active time.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Male and female
* BMI of 18.5-40 kg/m2 and weight stable over the previous 6 months.
* Age, 18-64 years old.
* Fasting glucose of 100-125 mg/dL or fasting HbA1c of 5.7-6.4%, or 2h OGTT blood glucose of 140-199mg/dL based on the American Diabetes Association criteria for pre-di…
Inclusion Criteria:
* Male and female
* BMI of 18.5-40 kg/m2 and weight stable over the previous 6 months.
* Age, 18-64 years old.
* Fasting glucose of 100-125 mg/dL or fasting HbA1c of 5.7-6.4%, or 2h OGTT blood glucose of 140-199mg/dL based on the American Diabetes Association criteria for pre-diabetes. Fasting glucose, HbA1c and OGTT results ordered by the participant's provider within 3-months of the screening visit will be accepted, provided they fall within the measurement of error range established by the institution's lab standards. Additionally, consistent use of Metformin (1 year) to prevent prediabetes from developing diabetes will be accepted.
* Less than 150 minutes of moderate-to-vigorous physical activity (MVPA) per week and more than 6 hours of sitting time per day, as self-reported by the volunteers using the International Physical Activity Questionnaire (IPAQ).
* Less than 6500 of steps per day as measured by a pedometer over 5 days (at least 1 weekend day).
* Passing medical and physical screening, and analysis of blood and urine screening samples.
* Low-moderate caffeine use (\<3 cups/day).
* Agree to refrain from any other structured exercise than the physical activity prescribed in each arm of the study.
* Agree to eat control diets for 3 days before and during the Clinical and Translational Research Center (CTRC) visits;
* Agree to refrain from taking any over-the-counter (including nonsteroidal anti-inflammatory drugs) or prescribed medication (apart from oral contraceptives) for 3 days prior to the inpatient CTRC visits;
* Agree to wear a Fitbit® activity monitor and upload data on the website on a daily basis for the whole duration of the study.
* Agree to follow the physical activity interventions and to be randomly assigned to one of the two arms of the study.
* Agree to complete all the study procedures.
Exclusion Criteria:
* Pregnancy, breast-feeding or post-menopause for women.
* Being considered unsafe to participate as determined by the study physician.
* Ever having a history of systemic, psychiatric, neurological disease, or drug and alcohol abuse.
* History of cardiovascular disease, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases, dyslipidemia or any other medical condition affecting weight or lipid metabolism.
* Being positive for human immunodeficiency virus or hepatitis B or C.
* Taking medications affecting weight, triglycerides, energy intake/energy expenditure, or sleep in the last 3 months.
* Having abnormal blood chemistry and/or hematology as deemed significant by the study physician.
* Being a smoker or having been a smoker in the 3 months prior to their screening visit.
* Having donated over 400 mL of blood within 3 months (90 days) of screening for the study;
* Working night shifts within 1 month of and throughout the study.
* Not completing the trial days of BREAK and ONE during the screening period to assess the willingness and ability of the participant to perform each of the interventions.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
